AMGN
Amgen Inc.
- Research and development, 2025
- $7.3B
- YoY, 2025
- +21.9%
- 5-year CAGR
- +11.6%
- 10-year CAGR
- +6.0%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $7.3B | +21.9% |
| 2024 | $6.0B | +24.7% |
| 2023 | $4.8B | +7.9% |
| 2022 | $4.4B | −8.0% |
| 2021 | $4.8B | +14.5% |
| 2020 | $4.2B | +2.2% |
| 2019 | $4.1B | +10.1% |
| 2018 | $3.7B | +4.9% |
| 2017 | $3.6B | −7.2% |
| 2016 | $3.8B | −5.7% |
| 2015 | $4.1B | −5.3% |
| 2014 | $4.3B | +5.2% |
| 2013 | $4.1B | +20.8% |
| 2012 | $3.4B | +6.7% |
| 2011 | $3.2B | +9.4% |
| 2010 | $2.9B | +1.0% |
| 2009 | $2.9B | −5.5% |
| 2008 | $3.0B | −7.2% |
| 2007 | $3.3B | — |